Table 2 Clinico-pathological characteristics stratified based on recurrence status

Age

Median (IQR)

63 (57–71)

71 (64–77)

0.002^a

FIGO Stage

1

46 (63)

12 (46)

0.064^b

2

4 (5)

3 (12)

3

20 (27)

5 (19)

4

2 (3)

6 (23)

Histology

Endometrioid

50 (69)

19 (73)

0.685^b

Serous Papillary/Clear cell

16 (23)

5 (19)

Carcinosarcoma

6 (8)

2 (8)

Lymph nodes

LN negative

58 (80)

18 (72)

0.500^c

LN positive

13 (20)

7 (28)

Unknown

1

1

Grade

1

14 (19)

3 (12)

0.841^b

2

27 (37)

12 (46)

3

30 (43)

11 (42)

Unknown

1

Risk status

Low risk

18 (25)

11 (42)

0.089^c

High risk

54 (75)

15 (58)

Adjuvant treatment

No Adjuvant treatment

5 (6)

2 (8)

0.297^b

Radiotherapy

44 (60)

10 (39)

Chemotherapy

10 (14)

9 (35)

Chemotherapy + radiotherapy

14 (20)

5 (19)

Median follow-up

5.36 (0.6–12.6)

2.63 (0.6–8.6)

(Years (range))